Literature DB >> 15001578

Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.

Giovanni Tulipano1, Ralf Stumm, Manuela Pfeiffer, Hans-Jürgen Kreienkamp, Volker Höllt, Stefan Schulz.   

Abstract

The physiological responses of somatostatin are mediated by five different G protein-coupled receptors. Although agonist-induced endocytosis of the various somatostatin receptor subtypes (sst(1)-sst(5)) has been studied in detail, little is known about their postendocytic trafficking. Here we show that somatostatin receptors profoundly differ in patterns of beta-arrestin mobilization and endosomal sorting. The beta-arrestin-dependent trafficking of the sst(2A) somatostatin receptor resembled that of a class B receptor in that upon receptor activation, beta-arrestin and the receptor formed stable complexes and internalized together into the same endocytic vesicles. This pattern was dependent on GRK2 (G protein-coupled receptor kinase 2)-mediated phosphorylation of a cluster of phosphate acceptor sites within the cytoplasmic tail of the sst(2A) receptor. Unlike other class B receptors, however, the sst(2A) receptor was rapidly resensitized and recycled to the plasma membrane. The beta-arrestin mobilization of the sst(3) and the sst(5) somatostatin receptors resembled that of a class A receptor in that upon receptor activation, beta-arrestin and the receptor formed relatively unstable complexes that dissociated at or near the plasma membrane. Consequently, beta-arrestin was excluded from sst(3)-containing vesicles. Unlike other class A receptors, a large proportion of sst(3) receptors was subject to ubiquitin-dependent lysosomal degradation and did not rapidly recycle to the plasma membrane. The sst(4) somatostatin receptor is unique in that it did not exhibit agonist-dependent receptor phosphorylation and beta-arrestin recruitment. Together, these findings may provide important clues about the regulation of receptor responsiveness during long-term administration of somatostatin analogs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001578     DOI: 10.1074/jbc.M313522200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients.

Authors:  Beatrice Waser; Renzo Cescato; Qisheng Liu; Yachu J Kao; Meike Körner; Emanuel Christ; Agnes Schonbrunn; Jean Claude Reubi
Journal:  Am J Pathol       Date:  2012-05       Impact factor: 4.307

2.  The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation.

Authors:  Erika Peverelli; Giovanna Mantovani; Davide Calebiro; Andrea Doni; Sara Bondioni; Andrea Lania; Paolo Beck-Peccoz; Anna Spada
Journal:  Mol Endocrinol       Date:  2007-12-20

Review 3.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

Review 4.  Selective agonism in somatostatin receptor signaling and regulation.

Authors:  Agnes Schonbrunn
Journal:  Mol Cell Endocrinol       Date:  2007-10-07       Impact factor: 4.102

Review 5.  Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5.

Authors:  Stefan Schulz; Andreas Lehmann; Andrea Kliewer; Falko Nagel
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

6.  Differential regulation of somatostatin receptor dephosphorylation by β-arrestin1 and β-arrestin2.

Authors:  Andrea Kliewer; Stefan Schulz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-26       Impact factor: 3.000

Review 7.  G protein-coupled receptor sorting to endosomes and lysosomes.

Authors:  Adriano Marchese; May M Paing; Brenda R S Temple; JoAnn Trejo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 8.  The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors.

Authors:  Mauro Cives; Jonathan Strosberg
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

9.  RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells.

Authors:  Deborah J Luessen; Tyler P Hinshaw; Haiguo Sun; Allyn C Howlett; Glen Marrs; Brian A McCool; Rong Chen
Journal:  Neuropharmacology       Date:  2016-08-12       Impact factor: 5.250

10.  Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.

Authors:  Florian Pöll; Diana Lehmann; Susann Illing; Mihaela Ginj; Stefan Jacobs; Amelie Lupp; Ralf Stumm; Stefan Schulz
Journal:  Mol Endocrinol       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.